Multi-Omic Profiling of Archival Tissue Samples

31 concepts23 papers1 proposal

For decades, clinical pathology departments have preserved patient tissue samples using a standard two-step process: fixing the tissue in formalin to preserve its cellular structure, and embedding it in paraffin wax blocks (FFPE). These archives represent a literal gold mine of clinical history, containing millions of specimens linked to long-term patient outcomes.

Historically, however, these samples were considered a graveyard for high-throughput molecular biology. The very process that preserves the tissue's shape destroys its molecular integrity. Formalin creates chemical crosslinks that lock proteins and nucleic acids into an unextractable mesh, while the embedding process causes RNA and DNA to degrade into tiny fragments. As a result, modern "omics" techniques—such as mass spectrometry and next-generation sequencing—traditionally required pristine, fresh-frozen tissue.

A multidisciplinary wave of research has fundamentally changed this paradigm. By designing extraction protocols that chemically reverse formalin crosslinks and engineering assays that embrace molecular fragmentation, researchers can now extract high-fidelity genomic, transcriptomic, proteomic, and metabolomic data directly from archival tissue blocks.


Reversing the Chemical Lock: Proteomics from FFPE

To understand why proteomic profiling of FFPE tissue was historically difficult, consider the chemistry of formalin fixation. Formalin reacts with primary amines in proteins to form highly stable methylene bridges ($-\text{CH}_2-$), crosslinking neighboring molecules into an insoluble network.

To liberate these proteins for mass spectrometry, researchers had to design a chemical "hammer" capable of breaking these bridges without destroying the underlying peptide bonds. As shown by Davidson et al., this can be achieved using an optimized lysis buffer that combines a cocktail of powerful detergents (Tris-HCl, SDS, SDC, and Triton X-100) with high-temperature heating. The heat provides the activation energy required to hydrolyze the methylene crosslinks, while the detergents solubilize the newly freed proteins.

Formalin Fixation:
Protein-NH2 + CH2O + HS-Protein  ──>  Protein-NH-CH2-S-Protein (Crosslinked Mesh)

Chemical Reversal (Optimized Lysis Buffer + High Heat):
Protein-NH-CH2-S-Protein + Heat/Detergents  ──>  Free, Soluble Proteins

Once the proteins are solubilized, achieving quantitative accuracy requires specialized downstream handling. Weißer et al. demonstrated that stable isotopic dimethylation—a robust and cost-effective chemical labeling method targeting primary amines—can be applied directly to FFPE-derived peptides. This technique achieves quantitative accuracy completely comparable to cryopreserved samples, proving that the fixation process does not inherently compromise the relative abundance of the proteome. To scale this process efficiently, Jin et al. utilized Pressure Cycling Technology (PCT) coupled with data-independent acquisition mass spectrometry (DIA-MS), accelerating tissue digestion and ensuring highly reproducible profiling of challenging clinical specimens.

The biological validity of this approach has been confirmed across various diseases. For example, Drendel et al. successfully used quantitative proteomics on archival blocks to distinguish between two kidney tumors that look nearly identical under a microscope (renal oncocytomas and chromophobe renal cell carcinomas), mapping distinct lysosomal and mitochondrial protein signatures. Similarly, Tang et al. leveraged archival profiling to identify an eight-protein "molecular switch" that drives skin cancer progression.

Taking this to the single-cell resolution, Mund et al. introduced Deep Visual Proteomics (DVP). By combining AI-driven image analysis of FFPE sections with automated laser microdissection and ultra-sensitive mass spectrometry, the authors linked exact visual cellular phenotypes directly to their underlying proteomic state, unlocking single-cell spatial proteomics in decades-old archives.


Sequencing the Shredded Blueprint: Genomics and Transcriptomics

While proteins are relatively robust, nucleic acids—particularly RNA—suffer severe degradation in archival blocks, often breaking down into fragments shorter than 200 nucleotides.

Traditional transcriptomics (RNA-seq) relies on "poly-A selection," a technique that captures mRNA molecules by grabbing their long poly-adenylated tails. In fragmented archival RNA, however, the poly-A tail is severed from the rest of the gene body. If you pull down only the tails, you lose the vast majority of the transcriptomic information.

To circumvent this, Conley et al. demonstrated that switching to a ribosomal RNA (rRNA) depletion workflow solves the problem. Instead of isolating mRNA by its tail, this method destroys the highly abundant ribosomal RNA, leaving all the fragmented pieces of mRNA behind to be sequenced. The authors showed that while the absolute length of the transcripts is shorter, the relative differences in gene expression between biological samples remain perfectly preserved, correlating strongly with fresh-frozen gold standards.

Traditional Poly-A Selection (Fails on Degraded RNA):
[Fragmented Gene Body]  ...  [Fragmented Gene Body]  ...  [Poly-A Tail] 
                                                             └──> Only this is captured!

Ribosomal RNA Depletion (Succeeds on Degraded RNA):
[Fragmented Gene Body]  [Fragmented Gene Body]  [Fragmented Gene Body] [rRNA - Destroyed]
  └──> All remaining fragments are sequenced and mapped back to the genome.

Other assay architectures tackle this by changing how the fragments are primed. April et al. developed the Whole-Genome DASL (cDNA-mediated Annealing, Selection, Extension, and Ligation) assay, which utilizes random priming across short target sequences. This approach achieves a 90% transcript detection overlap with fresh-frozen samples. For routine clinical deployment, Toussaint et al. showed that complex multi-gene diagnostic signatures can be "distilled" into simple, short-amplicon qRT-PCR tests, making advanced genomic grading accessible using standard hospital archives.

On the genomic and epigenetic front, DNA proves resilient enough for deep profiling. Kovaleva et al. adapted targeted next-generation sequencing (tNGS) to reliably map spatio-temporal mutations in colorectal cancer from minimal FFPE inputs, while Kontogianni et al. successfully executed exome-wide mutational profiling in cutaneous melanoma.

Furthermore, Hu demonstrated that archived FFPE tissue can be used for functional quantitative trait loci (fQTL) mapping to discover how genetic risk variants regulate complex biological pathways. This genomic stability extends to regulatory molecules and modifications as well: Kelly et al. established reproducible prognostic microRNA profiles from archival bone cancer samples, and Kong et al. validated the long-term stability of DNA methylation assays in stored clinical cytology specimens.


Spatial Mapping and the Small-Molecule Frontier

The evolution of archival tissue profiling extends beyond bulk extraction into spatial imaging and metabolomics.

A major hurdle in imaging FFPE tissue is autofluorescence—the chemical processing causes the tissue itself to glow under fluorescent light, masking true biological signals. To bypass this entirely, Jiang et al. developed a single-molecule chromogenic in situ hybridization (smCISH) assay. Instead of fluorescent tags, the assay uses direct RNA-templated padlock probes and rolling circle amplification to trigger an enzyme-catalyzed color reaction. This allows individual, degraded RNA molecules to be visualized and counted as distinct dots under standard bright-field microscopes, preserving spatial heterogeneity without fluorescence interference.

smCISH Mechanism (Bypassing Autofluorescence):
Target RNA Fragment + Padlock Probe ──> Ligation ──> Rolling Circle Amplification ──> Enzyme Color Reaction (Visible under standard bright-field)

Can volatile, small-molecule metabolites also survive the harsh embedding process? Surprisingly, yes. Wojakowska et al. optimized extraction protocols for Gas Chromatography/Mass Spectrometry (GC/MS) and discovered that approximately 75% of the metabolites present in fresh-frozen tissue remain detectable in FFPE blocks. This high level of preservation demonstrates that even the small-molecule "fingerprints" of disease remain stable over years of storage.


The New Era of Retrospective Research

The ability to extract high-quality multi-omic data from archived tissue fundamentally alters the timeline of clinical research. Large-scale tissue projects like the Genotype-Tissue Expression (GTEx) project, described by Lonsdale et al., established comprehensive baseline maps of human gene expression using post-mortem and surgical tissues.

By ensuring that modern genomic and proteomic profiling techniques are fully compatible with standard, even decalcified, clinical FFPE samples—as highlighted by Vora et al.—researchers no longer need to wait decades to collect fresh samples and track patient outcomes. Instead, they can look backward, deploying advanced multi-omic tools directly onto existing medical archives to discover biomarkers and therapeutic targets today.

Key Foundational Work

Pan-genomic/Pan-proteomic Approaches to Diseases (2010) — contributed 1 concept elements to this direction.
Whole-Genome Gene Expression Profiling of Formalin-Fixed, Paraffin-Embedded Tissue Samples (2009) — contributed 1 concept elements to this direction.
Improvement of the clinical applicability of the Genomic Grade Index through a qRT-PCR test performed on frozen and formalin-fixed paraffin-embedded tissues (2009) — contributed 1 concept elements to this direction.
History & citationVersion 1 · 2026-10-04

Current · Permanent link

View frozen version 1

Cite this direction

Latest version (a living page):

@misc{lacuna_archival_tissue_proteomics_bae813db,
  title = {archival tissue proteomics},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/archival-tissue-proteomics/rdr_bae813db5ec14c26a593426ea7103329},
  note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-19},
}

This exact version (version 1, frozen text):

@misc{lacuna_archival_tissue_proteomics_bae813db_v1,
  title = {archival tissue proteomics},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/archival-tissue-proteomics/rdr_bae813db5ec14c26a593426ea7103329/v/1},
  note = {Version 1, frozen 2026-10-04. Accessed 2026-11-19},
}
About

These directions overlap with this one through shared papers.

See something wrong? Report a mistake